H.U. Group Holdings
4544.TServices
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥247.4bn | ¥243.0bn | ¥236.9bn | ¥260.9bn | ¥272.9bn | ¥223.0bn |
| Operating income | ¥4.8bn | ¥2.6bn | −¥4.0bn | ¥23.4bn | ¥50.5bn | ¥25.4bn |
| Ordinary income | ¥2.8bn | ¥4.7bn | −¥7.2bn | ¥22.0bn | ¥47.4bn | ¥25.5bn |
| Net income (owners) | ¥6.8bn | ¥2.8bn | −¥7.6bn | ¥15.7bn | ¥29.6bn | ¥17.5bn |
| Total assets | ¥267.5bn | ¥279.6bn | ¥290.8bn | ¥297.9bn | ¥286.6bn | ¥252.8bn |
| Net assets / equity | ¥137.5bn | ¥137.3bn | ¥142.5bn | ¥150.0bn | ¥140.2bn | ¥115.3bn |
| Operating cash flow | ¥21.6bn | ¥22.0bn | ¥16.6bn | ¥32.5bn | ¥55.2bn | ¥35.6bn |
| EPS (basic) | ¥121.52 | ¥48.6 | ¥-132.77 | ¥275.52 | ¥519.55 | ¥306.38 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 72 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 71 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Clinical Lab Testing Business | ¥157.3bn | ¥31m |
| In Vitro Diagnostics Business | ¥60.7bn | ¥9.1bn |
| Sterilization And Related Services | ¥29.3bn | ¥1.8bn |
| Adjustments & eliminations | — | −¥6.1bn |
| Total | ¥247.4bn | ¥10.8bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.